NCT01614600

Brief Summary

The purpose of this study was to evaluate the reduction of contact lens-related dryness symptoms when symptomatic weekly/monthly contact lens wearers were switched to DAILIES® AquaComfort Plus® lenses for a two-week period using composite scores on the Contact Lens Dry Eye Questionnaire (CLDEQ).

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
88

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jun 2012

Shorter than P25 for not_applicable

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2012

Completed
5 days until next milestone

First Submitted

Initial submission to the registry

June 6, 2012

Completed
2 days until next milestone

First Posted

Study publicly available on registry

June 8, 2012

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2012

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2012

Completed
1.3 years until next milestone

Results Posted

Study results publicly available

December 4, 2013

Completed
Last Updated

December 4, 2013

Status Verified

September 1, 2013

Enrollment Period

3 months

First QC Date

June 6, 2012

Results QC Date

September 27, 2013

Last Update Submit

September 27, 2013

Conditions

Keywords

contact lensdry eye syndromesymptomaticdaily disposablemyopia

Outcome Measures

Primary Outcomes (1)

  • Mean Change From Baseline in Contact Lens-Related Dryness Symptoms at Week 1 and Week 2

    Contact lens symptoms were evaluated using the Contact Lens Dry Eye Questionnaire (CLDEQ). Subjects rated 8 common contact lens-related ocular surface dryness symptoms at Baseline, Week 1, and Week 2 using a 5-point scale (1=never or not at all intense, 5=constantly or very intense). A scoring algorithm was used to calculate a composite score for each visit for all symptoms (-6.5 to 10). A higher composite score would indicate more contact lens related dry eye and a lower score, less contact lens related dry eye.

    Baseline, Week 1, Week 2

Study Arms (1)

DAILIES® AquaComfort Plus®

EXPERIMENTAL

Nelfilcon A contact lenses worn bilaterally on a daily wear, daily disposable basis for 2 weeks

Device: Nelfilcon A contact lenses

Interventions

Commercially marketed hydrogel contact lenses for daily wear, daily disposable use

Also known as: DAILIES® AquaComfort Plus®
DAILIES® AquaComfort Plus®

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Currently wearing weekly/monthly, silicone hydrogel or traditional hydrogel soft contact lenses at least 8 hours per day and 5 days a week during the past 6 months.
  • Identified as symptomatic using a baseline screening questionnaire.
  • Requires vision correction in both eyes with a contact lens prescription as follows: sphere powers between -0.50 and -10.00 diopter (D) and cylinder powers \</= 0.75D and no ADD correction.
  • Able to achieve visual acuity (VA) of at least 6/7.5 in each eye with study lenses in the available parameters.
  • Willing to wear study lenses for at least 8 hours/day and at least 5 days/week and discard the lenses at the end of the day and replace lenses every day with a new fresh pair.
  • Willing and able to follow instructions and maintain the appointment schedule.

You may not qualify if:

  • Neophytes and current wearers of daily disposable contact lenses.
  • Requires monovision correction.
  • Any systemic or ocular disease or disorder (refractive disorder allowed) complicating factors or structural abnormality that would negatively affect the conduct or outcome of the study.
  • A history of ocular surgery/trauma within the last 6 months.
  • Unwilling to discontinue mechanical eyelid therapy or eyelid scrubs within 14 days of enrollment and continuing during the study.
  • Participation in any other ophthalmic drug or device clinical trial within 30 days of enrollment.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Dry Eye SyndromesMyopia

Condition Hierarchy (Ancestors)

Lacrimal Apparatus DiseasesEye DiseasesRefractive Errors

Results Point of Contact

Title
Jami Kern, MBA, PhD
Organization
Alcon Research, Ltd.

Study Officials

  • Jami Kern, MBA, PhD

    Alcon Research

    STUDY DIRECTOR

Publication Agreements

PI is Sponsor Employee
No
Restriction Type
OTHER
Restrictive Agreement
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 6, 2012

First Posted

June 8, 2012

Study Start

June 1, 2012

Primary Completion

September 1, 2012

Study Completion

September 1, 2012

Last Updated

December 4, 2013

Results First Posted

December 4, 2013

Record last verified: 2013-09